SpringerLink
Log in

Salvage SBRT for Local Recurrence of Prostate Cancer After Definitive Radiotherapy

  • Chapter
  • First Online:
Stereotactic Radiosurgery for Prostate Cancer

  • 601 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Abbreviations

2nd BCR:

Second biochemical recurrence

3DRT:

3-Dimensionnal Radiation Therapy

AAPM:

Association of Physicists in Medicine

ADT:

Androgen-deprivation therapy

BCR:

Biochemical recurrence

BT:

Brachytherapy

CTCAE:

Common Terminology Criteria for Adverse Events

CTV:

Clinical target volume

EAU-ESTO-SIOG:

European Association of Urology (EAU)–European Society for Radiotherapy & Oncology (ESTRO)–International Society of Geriatric Oncology (SIOG)

EBRT:

External beam radiation therapy

GI:

Gastro-intestinal

GTV:

Gross tumor volume

GU:

Genito-urinary

HDR:

High dose-rate

HIFU:

High Intensity Focused Ultrasound

IG-3D-CRT:

Image-guided 3D-CRT

IMRT:

Intensity Modulated Radiation Therapy

IPSS:

International Prostate Symptom Score

OARs:

Organ at risks

PCLR:

Prostate cancer local recurrence

PSA DT:

PSA doubling time

PTV:

Planning target volume

PVRV:

Post voiding residual volume

SBRT:

Stereotactic body radiation therapy

SRP:

Salvage radical prostatectomy

TRUS-biopsy:

Trans rectal ultrasound biopsy

References

  1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.

    Article  Google Scholar 

  2. Zumsteg ZS, Spratt DE, Romesser PB, Pei X, Zhang Z, Kollmeier M, et al. Anatomical patterns of recurrence following biochemical relapse in the dose escalation era of external beam radiotherapy for prostate cancer. J Urol. 2015;194(6):1624–30.

    Article  Google Scholar 

  3. Golbari NM, Katz AE. Salvage therapy options for local prostate cancer recurrence after primary radiotherapy: a literature review. Curr Urol Rep. 2017;18(8):63.

    Article  Google Scholar 

  4. Cornford P, Bellmunt J, Bolla M, Briers E, De Santis M, Gross T, et al. EAU-ESTRO-SIOG guidelines on prostate cancer. Part II: treatment of relapsing, metastatic, and castration-resistant prostate cancer. Eur Urol. 2017;71(4):630–42.

    Article  Google Scholar 

  5. Rocco B, Cozzi G, Spinelli MG, Grasso A, Varisco D, Coelho RF, et al. Current status of salvage robot-assisted laparoscopic prostatectomy for radiorecurrent prostate cancer. Curr Urol Rep. 2012;13(3):195–201.

    Article  Google Scholar 

  6. Bianco FJ, Scardino PT, Stephenson AJ, Diblasio CJ, Fearn PA, Eastham JA. Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy. Int J Radiat Oncol Biol Phys. 2005;62(2):448–53.

    Article  Google Scholar 

  7. Gotto GT, Yunis LH, Vora K, Eastham JA, Scardino PT, Rabbani F. Impact of prior prostate radiation on complications after radical prostatectomy. J Urol. 2010;184(1):136–42.

    Article  Google Scholar 

  8. Stephenson AJ, Eastham JA. Role of salvage radical prostatectomy for recurrent prostate cancer after radiation therapy. J Clin Oncol Off J Am Soc Clin Oncol. 2005;23(32):8198–203.

    Article  Google Scholar 

  9. Mandel P, Steuber T, Ahyai S, Kriegmair M, Schiffmann J, Boehm K, et al. Salvage radical prostatectomy for recurrent prostate cancer: verification of European Association of Urology guideline criteria. BJU Int. 2016;117(1):55–61.

    Article  Google Scholar 

  10. Chade DC, Eastham J, Graefen M, Hu JC, Karnes RJ, Klotz L, et al. Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature. Eur Urol. 2012;61(5):961–71.

    Article  Google Scholar 

  11. Yuh B, Ruel N, Muldrew S, Mejia R, Novara G, Kawachi M, et al. Complications and outcomes of salvage robot-assisted radical prostatectomy: a single-institution experience. BJU Int. 2014;113(5):769–76.

    Article  Google Scholar 

  12. Gamarra M, Astobieta A, Pereira JG, Leibar A, Ibarluzea G. Salvage high energy focalized ultrasound (HIFU) in prostate cancer after radiotherapy. Arch Esp Urol. 2012;65(1):101–10.

    PubMed  Google Scholar 

  13. Yutkin V, Ahmed HU, Donaldson I, McCartan N, Siddiqui K, Emberton M, et al. Salvage high-intensity focused ultrasound for patients with recurrent prostate cancer after brachytherapy. Urology. 2014;84(5):1157–62.

    Article  Google Scholar 

  14. de Castro Abreu AL, Bahn D, Leslie S, Shoji S, Silverman P, Desai MM, et al. Salvage focal and salvage total cryoablation for locally recurrent prostate cancer after primary radiation therapy. BJU Int. 2013;112(3):298–307.

    Article  Google Scholar 

  15. Chen CP, Weinberg V, Shinohara K, Roach M, Nash M, Gottschalk A, et al. Salvage HDR brachytherapy for recurrent prostate cancer after previous definitive radiation therapy: 5-year outcomes. Int J Radiat Oncol Biol Phys. 2013;86(2):324–9.

    Article  Google Scholar 

  16. Henríquez I, Sancho G, Hervás A, Guix B, Pera J, Gutierrez C, et al. Salvage brachytherapy in prostate local recurrence after radiation therapy: predicting factors for control and toxicity. Radiat Oncol. 2014;9:102.

    Article  Google Scholar 

  17. Mbeutcha A, Chauveinc L, Bondiau P-Y, Chand M-E, Durand M, Chevallier D, et al. Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy. Radiat Oncol. 2017;12(1):49.

    Article  Google Scholar 

  18. Vargas C, Swartz D, Vashi A, Blasser M, Kasraeian A, Cesaretti J, et al. Salvage brachytherapy for recurrent prostate cancer. Brachytherapy. 2014;13(1):53–8.

    Article  Google Scholar 

  19. Ramey SJ, Marshall DT. Re-irradiation for salvage of prostate cancer failures after primary radiotherapy. World J Urol. 2013;31(6):1339–45.

    Article  Google Scholar 

  20. Arcangeli S, Agolli L, Donato V. Retreatment for prostate cancer with stereotactic body radiation therapy (SBRT): Feasible or foolhardy? Rep Pract Oncol Radiother. 2015;20(6):425–9.

    Article  Google Scholar 

  21. Vavassori A, Jereczek-Fossa BA, Beltramo G, De Cicco L, Fariselli L, Bianchi LC, et al. Image-guided robotic radiosurgery as salvage therapy for locally recurrent prostate cancer after external beam irradiation: retrospective feasibility study on six cases. Tumori J. 2010;96(1):71–5.

    Article  Google Scholar 

  22. Fuller DB, Wurzer J, Shirazi R, Bridge SS, Law J, Mardirossian G. High-dose-rate stereotactic body radiation therapy for postradiation therapy locally recurrent prostatic carcinoma: preliminary prostate-specific antigen response, disease-free survival, and toxicity assessment. Pract Radiat Oncol. 2015;5(6):e615–23.

    Article  Google Scholar 

  23. Leroy T, Lacornerie T, Bogart E, Nickers P, Lartigau E, Pasquier D. Salvage robotic SBRT for local prostate cancer recurrence after radiotherapy: preliminary results of the Oscar Lambret Center. Radiat Oncol. 2017;12:95.

    Article  Google Scholar 

  24. Janoray G, Reynaud-Bougnoux A, Ruffier-Loubière A, Bernadou G, Pointreau Y, Calais G. Stereotactic body re-irradiation therapy for locally recurrent prostate cancer after external-beam radiation therapy: initial report. Cancer Radiother J Soc Francaise Radiother Oncol. 2016;20(4):275–81.

    CAS  Google Scholar 

  25. Detti B, Bonomo P, Masi L, Doro R, Cipressi S, Iermano C, et al. CyberKnife stereotactic radiotherapy for isolated recurrence in the prostatic bed. World J Urol. 2016;34(3):311–7.

    Article  CAS  Google Scholar 

  26. Zerini D, Jereczek-Fossa BA, Fodor C, Bazzani F, Maucieri A, Ronchi S, et al. Salvage image-guided intensity modulated or stereotactic body reirradiation of local recurrence of prostate cancer. Br J Radiol. 2015;88(1052):20150197.

    Article  CAS  Google Scholar 

  27. Jereczek-Fossa BA, Beltramo G, Fariselli L, Fodor C, Santoro L, Vavassori A, et al. Robotic image-guided stereotactic radiotherapy, for isolated recurrent primary, lymph node or metastatic prostate cancer. Int J Radiat Oncol Biol Phys. 2012;82(2):889–97.

    Article  Google Scholar 

  28. **e Y, Djajaputra D, King CR, Hossain S, Ma L, **ng L. Intrafractional motion of the prostate during hypofractionated radiotherapy. Int J Radiat Oncol Biol Phys. 2008;72(1):236–46.

    Article  Google Scholar 

  29. Benedict SH, Lin PS, Zwicker RD, Huang DT, Schmidt-Ullrich RK. The biological effectiveness of intermittent irradiation as a function of overall treatment time: development of correction factors for linac-based stereotactic radiotherapy. Int J Radiat Oncol Biol Phys. 1997;37(4):765–9.

    Article  CAS  Google Scholar 

  30. Fowler JF, Welsh JS, Howard SP. Loss of biological effect in prolonged fraction delivery. Int J Radiat Oncol Biol Phys. 2004;59(1):242–9.

    Article  Google Scholar 

  31. Philippou Y, Parker RA, Volanis D, Gnanapragasam VJ. Comparative oncologic and toxicity outcomes of salvage radical prostatectomy versus nonsurgical therapies for radiorecurrent prostate cancer: a meta-regression analysis. Eur Urol Focus. 2016;2(2):158–71.

    Article  Google Scholar 

  32. Kan RW, Kan C, Ho L, Chan SW. Pre-operative tumor localization and evaluation of extra-capsular extension of prostate cancer: how misleading can it be? Urol J. 2014;11(3):1615–9.

    PubMed  Google Scholar 

  33. Zelefsky MJ, Kollmeier MA, McBride S, Pei X, Happersett L, Lin M, et al. 5-Year outcomes of a phase 1 dose escalation study using stereotactic body radiosurgery for patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 2017;99(2):S156–7.

    Article  Google Scholar 

  34. Loblaw DA, Virgo KS, Nam R, Somerfield MR, Ben-Josef E, Mendelson DS, et al. Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol. 2007;25(12):1596–605.

    Article  CAS  Google Scholar 

  35. Garcia-Albeniz X, Chan JM, Paciorek A, Logan RW, Kenfield SA, Cooperberg MR, et al. Immediate versus deferred initiation of androgen deprivation therapy in prostate cancer patients with PSA-only relapse. An observational follow-up study. Eur J Cancer. 2015;51(7):817–24.

    Article  CAS  Google Scholar 

  36. Ahmadi H, Daneshmand S. Androgen deprivation therapy: evidence-based management of side effects. BJU Int. 2013;111(4):543–8.

    Article  CAS  Google Scholar 

  37. Kaljouw E, Pieters BR, Kovács G, Hoskin PJ. A Delphi consensus study on salvage brachytherapy for prostate cancer relapse after radiotherapy, a Uro-GEC study. Radiother Oncol. 2016;118(1):122–30.

    Article  Google Scholar 

  38. Rouvière O, Vitry T, Lyonnet D. Imaging of prostate cancer local recurrences: why and how? Eur Radiol. 2010;20(5):1254–66.

    Article  Google Scholar 

  39. Abd-Alazeez M, Ramachandran N, Dikaios N, Ahmed HU, Emberton M, Kirkham A, et al. Multiparametric MRI for detection of radiorecurrent prostate cancer: added value of apparent diffusion coefficient maps and dynamic contrast-enhanced images. Prostate Cancer Prostatic Dis. 2015;18(2):128–36.

    Article  CAS  Google Scholar 

  40. Mitchell CR, Lowe VJ, Rangel LJ, Hung JC, Kwon ED, Karnes RJ. Operational characteristics of (11)c-choline positron emission tomography/computerized tomography for prostate cancer with biochemical recurrence after initial treatment. J Urol. 2013;189(4):1308–13.

    Article  Google Scholar 

  41. Rybalov M, Breeuwsma AJ, Leliveld AM, Pruim J, Dierckx RA, de Jong IJ. Impact of total PSA, PSA doubling time and PSA velocity on detection rates of 11C-Choline positron emission tomography in recurrent prostate cancer. World J Urol. 2013;31(2):319–23.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Antoine LACASSAGNE Cancer Center, University of Cote d’Azur, Nice, France

    Daniel Lam Cham Kee, Jérôme Doyen, Alexander T. Falk & Jean-Michel Hannoun-Levi

Authors
  1. Daniel Lam Cham Kee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jérôme Doyen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alexander T. Falk
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jean-Michel Hannoun-Levi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jean-Michel Hannoun-Levi .

Editor information

Editors and Affiliations

  1. Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, USA

    Michael J. Zelefsky

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Lam Cham Kee, D., Doyen, J., Falk, A.T., Hannoun-Levi, JM. (2019). Salvage SBRT for Local Recurrence of Prostate Cancer After Definitive Radiotherapy. In: Zelefsky, M. (eds) Stereotactic Radiosurgery for Prostate Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-92453-3_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-92453-3_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-92452-6

  • Online ISBN: 978-3-319-92453-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation